Financhill
Back

Intra-Cellular Therapies Stock Predictions

Intra-Cellular Therapies Stock Forecast

  • Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 36.2% based on the past 9 years of stock performance.
  • Intra-Cellular Therapies has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
  • Is Intra-Cellular Therapies Stock Undervalued?
    The current Intra-Cellular Therapies [ITCI] share price is $61.32. The Score for ITCI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

  • Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 36.2% based on the past 9 years of stock performance.

Intra-Cellular Therapies Stock Rating

Sell
44
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies overpriced?

  • Intra-Cellular Therapies has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
Type:
stock
Website:
intracellulartherapies.com

52-Week Data

52-Week High:
66.56
52-Week Low:
42.01

Prediction Charts

Market Cap:
5.88B
Price in USD:
61.32
Volume:
633.41K
Beta:
1.06

Technical Analysis

SMA50:
60.11
SMA100:
53.83
SMA200:
51.82
52-Wk Change:
10.17%

Stock Predictions

  • Is Intra-Cellular Therapies stock public?
    Yes, Intra-Cellular Therapies is a publicly traded company.
  • What is the Intra-Cellular Therapies stock quote today?
    The Intra-Cellular Therapies stock price is 61.32 USD today.
  • How to buy Intra-Cellular Therapies stock online?
    You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-15 64.50 64.91 65.59 64.21
May-16 63.80 63.14 63.80 61.92
May-17 63.24 63.41 64.15 62.21
May-18 63.50 62.98 64.04 62.18
May-19 63.48 62.42 63.55 62.17
May-22 62.66 62.64 63.23 62.07
May-23 62.59 61.83 63.89 61.42
May-24 61.64 61.00 62.22 60.48
May-25 61.00 60.17 62.16 59.13
May-26 60.07 60.20 60.72 59.77
May-30 60.06 59.43 60.25 59.31
May-31 59.91 59.37 61.00 59.31
Jun-1 59.28 59.53 60.46 58.33
Jun-2 60.09 61.32 61.66 59.03

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.39 per share, an increase this year of $0.59 per share, and an increase next year of $1.60 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.